Epidemiology of bacterial colonization at intensive care unit admission with emphasis on extended-spectrum β-lactamase- and metallo-β-lactamase-producing Gram-negative bacteria – an Indian experience
An important risk factor for nosocomial infection in an intensive care unit (ICU) is prior colonization. This study was undertaken to determine the spectrum of bacterial colonization and predisposing risk factors in patients being admitted to an ICU in India, with special emphasis on extended-spectrum β-lactamase (ESBL)- and metallo-β-lactamase (MBL)-producing Gram-negative bacteria. Nasal, oral and rectal swab samples were collected and processed for isolation of ESBL-producing Gram-negative bacteria and MBL-producing Pseudomonas aeruginosa and Acinetobacter species. Bacterial colonization (of one or more sites) on admission was detected in 51 out of 96 patients included in the study. Non-fermenters, i.e. P. aeruginosa and Acinetobacter baumannii, were the most common colonizers, present in 37 patients, with simultaneous colonization in 12 patients. A total of 16 patients were colonized with MBL-producing members of the family Enterobacteriaceae, out of which 11 isolates (from 5 patients) were also carrying ESBL-encoding genes. As for MBLs, most of our patients have shown colonization with ESBL-producing bacteria. On admission, 47 of 51 patients (92 %) have been colonized by ESBL-producing members of the family Enterobacteriaceae, at one or more of the three anatomical sites. The most common MBL subtype was blaIMP (51.56 %), whereas blaCTX was the most common gene (84.9 %) identified among ESBL producers. Risk factors for colonization on admission to the ICU were hospitalization for more than 48 h, use of ≥3 groups of antibiotics, co-morbidities and mechanical ventilation for more than 48 h prior to ICU admission. There is an increasing incidence of MBLs and ESBLs in the Indian population. The identified risk factors can be used as a guide for empiric antibiotic therapy targeted to these resistant bacteria.
BontenM. J.,
WeinsteinR. A.1996; The role of colonization in the pathogenesis of nosocomial infections. Infect Control Hosp Epidemiol 17:193–200[CrossRef]
BontenM. J.,
HaydenM. K.,
NathanC.,
van VoorhisJ.,
MatushekM.,
SlaughterS.,
RiceT.,
WeinsteinR. A.1996; Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci
. Lancet 348:1615–1619[CrossRef]
BrenwaldN. P.,
JevonsG.,
AndrewsJ. M.,
XiongJ. H.,
HawkeyP. M.,
WiseR.2003; An outbreak of a CTX-M-type β -lactamase-producing Klebsiella pneumoniae : the importance of using cefpodoxime to detect extended-spectrum β -lactamases. J Antimicrob Chemother 51:195–196[CrossRef]
Bryan-BrownC. W.1992; Pathway to the present: a personal view of critical care. In Critical Care , 2nd edn. pp 5–6 Edited by
CivettaJ. M.,
TaylorR. W.,
KirbyR. R.
Philadelphia, PA: J. B. Lippincott;
EnsorV. M.,
ShahidM.,
EvansJ. T.,
HawkeyP. M.2006; Occurrence, prevalence and genetic environment of CTX-M β -lactamases in Enterobacteriaceae from Indian hospitals. J Antimicrob Chemother 58:1260–1263[CrossRef]
HarrisA. D.,
McGregorJ. C.,
JohnsonJ. A.,
StraussS. M.,
MooreA. C.,
StandifordH. C.,
HebdenJ. N.,
MorrisJ. G.Jr2007; Risk factors for colonization with extended-spectrum β -lactamase-producing bacteria and intensive care unit admission. Emerg Infect Dis 13:1144–1149[CrossRef]
HeylandD. K.,
CookD. J.,
GriffithL.,
KeenanS. P.,
Brun BuissonC.for the Canadian Critical Care Trials Group1999; The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. Am J Respir Crit Care Med 159:1249–1256[CrossRef]
JarvisW. R.1996; Selected aspects of socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention. Infect Control Hosp Epidemiol 17:552–557[CrossRef]
LuzzaroF.,
MezzatestaM.,
MugnaioliC.,
PerilliM.,
StefaniS.,
AmicosanteG.,
RossoliniG. M.,
TonioloA.2006; Trends in production of extended-spectrum β -lactamases among enterobacteria of medical interest: report of the second Italian nationwide survey. J Clin Microbiol 44:1659–1664[CrossRef]
Muzaheed DoiY.,
Adams-HaduchM. J.,
EndimianiA.,
SidjabatH. E.,
GaddadS. M.,
PatersonD. L.2008; High prevalence of CTX-M-15-producing Klebsiella pneumoniae among inpatients and outpatients with urinary tract infection in Southern India. J Antimicrob Chemother 61:1393–1394[CrossRef]
NCCLS2000; Performance Standards for Antimicrobial Disk Susceptibility Test , approved standard. , 7th edn. vol. 20 no. 1M2–A7 Wayne, PA: National Committee for Clinical Laboratory Standards;
PournarasS.,
IkonomidisA.,
KristoI.,
TsakrisA.,
ManiatisA. N.2004; CTX-M enzymes are the most common extended-spectrum β -lactamases among Escherichia coli in a tertiary Greek hospital. J Antimicrob Chemother 54:574–575[CrossRef]
SambrookJ.,
FritschE. F.,
MiniatisT.1989; Extraction and purification of plasmid DNA. In Molecular Cloning: a Laboratory Manual , 2nd edn. pp. 1.32–1.34 Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
Epidemiology of bacterial colonization at intensive care unit admission with emphasis on extended-spectrum β-lactamase- and metallo-β-lactamase-producing Gram-negative bacteria – an Indian experience